September 2, 2014

FDA continues to turn a deaf ear to consumers regarding supplements

pin it button FDA continues to turn a deaf ear to consumers regarding supplements

iStock 000016803962XSmall 300x199 FDA continues to turn a deaf ear to consumers regarding supplements

By Lee Bechtel
National Health Federation

The Food and Drug Administration (FDA) has continued to turn a deaf ear to consumers and their health in pushing forward its agenda to remove thousands of safe supplements from the American marketplace.

The FDA is Deaf and Dumb

Daniel Fabricant, Ph.D., the director of the Division of Dietary Supplement Programs at the FDA, again has stated that the Agency has no intention of withdrawing its proposed Draft Guidance for New Dietary Supplement Ingredients (NDIs) that it published last July. The FDA has not changed its position despite receiving over 7,000 comments on the draft industry guidance, which would subject many thousands of supplements to very expensive, drug-like testing and approval requirements in order to stay on store shelves.

Fabricant says “alternative approaches” by the FDA to satisfy the FDA’s proposed requirements in the NDI Guidance might be reviewed. However there was no clarification on whether the requirements imposing prescription-drug-like clinical testing and scientific testing to gain FDA approval for supplements sold since 1986 and in the future would be subject to amendment, or dropped from the Guidance. He had previously implied that it could take 3-4 years to resolve these issues but now says the timeline “is really up in the air.” Fabricant’s comments can be read at http://www.nutraingredients-usa.com/Regulation/Fabricant-on-NDI-draft-guidance-Thanks-for-your-146-000-pages-of-comments.-We-ll-get-back-to-you. Interestingly enough, before joining the FDA in February 2011, Fabricant was a vice president with the Natural Products Association (NPA), which makes it very clear that Fabricant has abandoned his obviously sparse roots along with whatever understanding he ever had of the industry.

The FDA Blames Industry & Punishes the Consumer

More telling about the FDA’s strategy for more heavy-handed regulation is the statement that “If you look at the numbers of NDI submissions versus the number of supplements introduced to the market since 1994, it would appear there is a significant lag in compliance.” On its face, the marketplace has changed over the last seventeen years. But who is responsible for this 17-year lag in compliance?

The Dietary Supplement Health and Education Act of 1994 (DSHEA) required manufacturers to submit pre-market notification applications for supplements and new ingredients when there is a history of use or other evidence establishing that an ingredient is safe when used as directed. The FDA has 75 days to accept or reject the application. A non-decision by the FDA means that the Agency accepts the evidence and that the product has complied, is approved, and can be marketed to the consuming public.  Alternatively, a formal petition for a review and FDA issuance of an order prescribing the conditions under which a new dietary ingredient can be used and reasonably be expected to be safe, with the FDA having to respond within 180 days, can be filed. Again, shouldn’t a non-decision on a petition be considered as final Agency approval? If the Agency does not issue a decision either way, or if it cannot find a decision that was issued over the previous seventeen years, has it been the industry or the FDA itself who has not been in compliance with DSHEA?

Apparently, the FDA believes that manufacturers and suppliers have not met the FDA’s own self-interpreted DSHEA burden of proof standard to show to the FDA that there is reasonable evidence that supplements and new ingredients in supplements are safe. The NHF believes, based upon the DSHEA law language, that this is a total misapplication of the DSHEA burden-of-proof standard. The burden of proof has been, and is on, the FDA to prove that supplements, which they have de facto approved through the pre-marketing notification process, are unsafe in the post-marketing stage of consumer use.

Since DSHEA, there have been seventeen years of additional historical use-safety experience conducted by many millions of Americans. The FDA is choosing to ignore evidence and is attempting to paint this as non-compliance. In other words, it has not done its job but instead claims that it is not the FDA’s fault – instead, supplement consumers and industry should pay the price.

Take Action Now

The NHF has created a solution for all of us to rally behind – the Dietary Supplement Protection Act (DSPA) as H.R.3380.  Some timid souls in the industry cower in a corner, saying they are afraid to support this bill because it will “open up DSHEA.”  In case they had not already realized it, DSHEA gets “opened up” by our anti-health-freedom opponents each and every year with their new legislation!  Are we to be nothing but cowards when we have the chance to regain some of our own freedoms?  The NHF isn’t and knows that we need to be as bold as, even bolder than, our opponents.

Both companies and consumers must support H.R.3380, especially when Congress gets back to work in mid-January 2012. The bill changes a key date in the DSHEA law that will save thousands of our supplements.  It does this by acknowledging and using in our favor the new regulatory environment for supplements as well as supplements’ incredible safety record. It will put FDA bureaucrat’s feet to the fire and an end to their seventeen-year efforts to salami-slice the DSHEA law to fit their own public-policy agenda for dietary supplements.

Information on H.R.3380 and how to contact your member of Congress to sponsor H.R.3380 is available on the NHF webpage at: http://www.thenhf.com/page.php?id=295. The NHF needs everyone to contact their representatives and urge them to co-sponsor H.R.3380.  We need the same consumer outrage that was seen pre-DSHEA to make this legislation a reality.  Be bold and be persistent.

Read the Full Article Here: http://www.thenhf.com/article.php?id=3160

Global Censorship of Health Information
The Politics of Controlling Therapeutic Information to Protect State-Sponsored Drug Monopolies

Global Censorship of Health Information book coversm FDA continues to turn a deaf ear to consumers regarding supplements

by Attorney Jonathan Emord
Free Shipping available!

0 commentsback to post

Other articlesgo to homepage

Study: Legalizing Medical Marijuana Leads to Fewer Prescription Drug Overdose Deaths

Study: Legalizing Medical Marijuana Leads to Fewer Prescription Drug Overdose Deaths

Pin It

A study published in the journal JAMA Internal Medicine on Monday found that states that had legalized medical marijuana had seen a 25 percent drop in deaths related to prescription drug overdoses.

According to ABC News, the researchers conducting the study found that because “legalizing medical marijuana makes it more available to chronic pain patients, it provides a potentially less lethal alternative to pain control on a long-term basis.”

Over the course of the study, the states studied were the ones that allowed access to medical marijuana. The Washington Post reported that those states “had 1,729 fewer overdose deaths in 2010 than would be predicted by trends in states without such laws.”

Dr. Marcus Bachhuber, a physician and researcher at the University of Pennsylvania, and the lead author of the study, told ABC News that while he did expect to see changes among the states that legalized medical marijuana, he found it “surprising that the difference is so big.”

Unapproved but Effective Cancer Cures

Unapproved but Effective Cancer Cures

Pin It

The conventional cancer treatment system and the pharmaceutical companies that control it are dedicated to limiting the development of all other forms of cancer treatment. They have a chokehold on the development of alternative treatments, and they ruthlessly work together with the US FDA and various US government cancer research funding agencies to prevent new treatments from being approved for use by physicians. The reason is that most alternative cancer treatments are much less expensive than surgery, radiation, and chemo. They are also more effective and have many fewer (if any) unwanted side effects.

The great fear of the pharmaceutical industry, and the vast cancer treatment system that it controls, is that a non-patentable and inexpensive cure for cancer might put them out of business. Sadly, these organizations exist to turn a profit from cancer treatment, which is measured in the billions of dollars every year. They are in the business of treating cancer not curing it.

Alternative treatments for cancer have a history of curing cancer and it is this fact that big pharma wants to hide from the American public. Historically, many successful approaches have been developed for curing cancer. We give a review of many of the most popular ones here.

Report: FDA Deliberately Deceptive – Poisoning Millions of Americans

Report: FDA Deliberately Deceptive – Poisoning Millions of Americans

Pin It

US consumers are in dark about mercury in dental products—and they are kept there deliberately by the government. This is documented in a new report being released this week by Consumers for Dental Choice called “Measurably Misleading: Evidence the FDA and Dental Industry are Deliberately Deceiving American Families about Mercury Dental Fillings and Why That Now Has International Consequences.”

Mercury is a known neurotoxin, yet mercury fillings presents one of the largest consumer consumption of mercury worldwide, and dental amalgam represents the largest use of mercury in consumer products in the US. We’ve also been kept in in the dark about mercury in other consumer products because of the FDA. Thimerosal, a mercury compound often found in flu vaccines, is being ignored as a danger.

Detox Your Liver with Homemade Lemon Water

Detox Your Liver with Homemade Lemon Water

Pin It

One of the drinks I routinely make for myself and my family in the mornings is lemon water. Not to be confused with “lemonade,” a sweetened beverage, lemon water is a detoxifying health drink consisting of nothing but one whole lemon and warm water.

Much of the research on lemon water’s ability to detoxify the liver is centered around the antioxidant D-Limonene, which is more concentrated in the peel of the lemon. D-limonene has been shown to activate enzymes in the liver that lead to detoxification. It has also been shown to treat cancer.

The Healing Properties of Clove Essential Oil

The Healing Properties of Clove Essential Oil

Pin It

The ancient texts all seem to agree on the many therapeutic properties of clove – it is a stimulant and has stomachic, expectorant, sedative, carminative, antispasmodic and digestive qualities. It helps flatulence, stimulates digestion and restores appetite, so is good for convalescence. It is a general tonic for both physical and intellectual weakness; and for those suffering from frigidity.

Its principal therapeutic value, though, is antiseptic because of the high proportion of eugenol. This is used for intestinal parasites, and for prevention of virus infections. It is good for the immune system, and particularly effective in mouth and tooth infections.

Here is a review of some of scientific studies published around the world regarding the healing properties of clove essential oil.

read more


Get the news right in your inbox!